JP2017523225A5 - - Google Patents

Download PDF

Info

Publication number
JP2017523225A5
JP2017523225A5 JP2017506964A JP2017506964A JP2017523225A5 JP 2017523225 A5 JP2017523225 A5 JP 2017523225A5 JP 2017506964 A JP2017506964 A JP 2017506964A JP 2017506964 A JP2017506964 A JP 2017506964A JP 2017523225 A5 JP2017523225 A5 JP 2017523225A5
Authority
JP
Japan
Prior art keywords
alkyl
substituted
carboxylic acid
formula
heterocycle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017506964A
Other languages
English (en)
Japanese (ja)
Other versions
JP6577570B2 (ja
JP2017523225A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2015/068257 external-priority patent/WO2016020526A1/en
Publication of JP2017523225A publication Critical patent/JP2017523225A/ja
Publication of JP2017523225A5 publication Critical patent/JP2017523225A5/ja
Application granted granted Critical
Publication of JP6577570B2 publication Critical patent/JP6577570B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017506964A 2014-08-08 2015-08-07 インフルエンザウイルス感染に使用するためのインドール類 Expired - Fee Related JP6577570B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14180331.2 2014-08-08
EP14180331 2014-08-08
PCT/EP2015/068257 WO2016020526A1 (en) 2014-08-08 2015-08-07 Indoles for use in influenza virus infection

Publications (3)

Publication Number Publication Date
JP2017523225A JP2017523225A (ja) 2017-08-17
JP2017523225A5 true JP2017523225A5 (cg-RX-API-DMAC7.html) 2019-08-22
JP6577570B2 JP6577570B2 (ja) 2019-09-18

Family

ID=51298610

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017506964A Expired - Fee Related JP6577570B2 (ja) 2014-08-08 2015-08-07 インフルエンザウイルス感染に使用するためのインドール類

Country Status (18)

Country Link
US (1) US10597390B2 (cg-RX-API-DMAC7.html)
EP (1) EP3177609A1 (cg-RX-API-DMAC7.html)
JP (1) JP6577570B2 (cg-RX-API-DMAC7.html)
KR (1) KR102488479B1 (cg-RX-API-DMAC7.html)
CN (1) CN106573920B (cg-RX-API-DMAC7.html)
AU (1) AU2015298876B2 (cg-RX-API-DMAC7.html)
BR (1) BR112017002370B1 (cg-RX-API-DMAC7.html)
CA (1) CA2954751C (cg-RX-API-DMAC7.html)
CL (1) CL2017000309A1 (cg-RX-API-DMAC7.html)
EA (1) EA201790266A1 (cg-RX-API-DMAC7.html)
IL (1) IL250408B (cg-RX-API-DMAC7.html)
MA (1) MA40547A (cg-RX-API-DMAC7.html)
MX (1) MX381488B (cg-RX-API-DMAC7.html)
PH (1) PH12017500207B1 (cg-RX-API-DMAC7.html)
SG (1) SG11201700956VA (cg-RX-API-DMAC7.html)
UA (1) UA124609C2 (cg-RX-API-DMAC7.html)
WO (1) WO2016020526A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201700952B (cg-RX-API-DMAC7.html)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2442809T3 (pl) 2009-06-17 2017-02-28 Vertex Pharmaceuticals Incorporated Inhibitory replikacji wirusów grypy
UA118010C2 (uk) 2011-08-01 2018-11-12 Вертекс Фармасьютікалз Інкорпорейтед Інгібітори реплікації вірусів грипу
SG11201700956VA (en) 2014-08-08 2017-03-30 Janssen Sciences Ireland Uc Indoles for use in influenza virus infection
WO2016183120A1 (en) 2015-05-13 2016-11-17 Vertex Pharmaceuticals Incorporated Inhibitors of influenza viruses replication
JP6704416B2 (ja) 2015-05-13 2020-06-03 バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated インフルエンザウイルスの複製の阻害剤を調製する方法
US10717732B2 (en) 2015-12-09 2020-07-21 Sunshine Lake Pharma Co., Ltd. Inhibitors of influenza virus replication, application methods and uses thereof
EA201891576A1 (ru) * 2016-01-07 2018-11-30 Янссен Сайенсиз Айрлэнд Юси Функционализированные пентановые кислоты для применения при инфекциях, вызванных вирусом гриппа
WO2017133670A1 (en) * 2016-02-05 2017-08-10 Savira Pharmaceuticals Gmbh Pyridine and pyrimidine derivatives and their use in treatment, amelioration or prevention of influenza
CN107759571B (zh) * 2016-08-16 2021-03-02 广东东阳光药业有限公司 流感病毒复制抑制剂及其使用方法和用途
WO2018041091A1 (en) * 2016-08-30 2018-03-08 Sunshine Lake Pharma Co., Ltd. Inhibitors of influenza virus replication, application methods and uses thereof
CN109790159B (zh) 2016-09-05 2020-01-14 广东众生睿创生物科技有限公司 抗流感病毒嘧啶衍生物
KR102554019B1 (ko) 2016-12-15 2023-07-11 선샤인 레이크 파르마 컴퍼니 리미티드 인플루엔자 바이러스 복제의 억제제 및 이의 용도
WO2018119395A1 (en) * 2016-12-23 2018-06-28 Aquinnah Pharmaceuticals, Inc. Compouns, compositions and methods of use
CN108276401B (zh) 2017-01-05 2020-12-22 广东东阳光药业有限公司 流感病毒复制抑制剂及其用途
WO2018157830A1 (en) 2017-03-02 2018-09-07 Sunshine Lake Pharma Co., Ltd. Inhibitors of influenza virus replication and uses thereof
CN108727369B (zh) * 2017-04-25 2023-06-09 广东东阳光药业有限公司 流感病毒复制抑制剂及其用途
TWI794433B (zh) * 2018-03-05 2023-03-01 大陸商廣東衆生睿創生物科技有限公司 吡啶并吡唑類化合物的晶型、鹽型及其製備方法
JP7450017B2 (ja) 2019-07-22 2024-03-14 広東衆生睿創生物科技有限公司 ピリミジン誘導体の優位な塩形およびその結晶形
CN113045475A (zh) * 2019-12-27 2021-06-29 上海泓博智源医药股份有限公司 一种5-溴-7-甲基吲哚的制备方法
CA3185649A1 (en) * 2020-07-20 2022-01-27 Bakary-Barry Toure Indole compounds as androgen receptor modulators
EP4214201A4 (en) * 2020-09-18 2024-10-09 Sunshine Lake Pharma Co., Ltd. PROCESS FOR THE PREPARATION OF SUBSTITUTED PYRIMIDINE PIPERAZINE COMPOUNDS
PE20251586A1 (es) * 2022-10-12 2025-06-16 Maze Therapeutics Inc Inhibidores del miembro 19 de la familia de portadores de solutos 6a (slc6a19) y metodos de uso de los mismos

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2332940T3 (pl) 2004-03-30 2013-03-29 Vertex Pharma Azaindole użyteczne jako inhibitory JAK i innych kinaz białkowych
TWI424999B (zh) 2006-01-17 2014-02-01 Vertex Pharma 適合作為傑納斯激酶(janus kinase)抑制劑之氮雜吲哚
PL2442809T3 (pl) * 2009-06-17 2017-02-28 Vertex Pharmaceuticals Incorporated Inhibitory replikacji wirusów grypy
JP5876051B2 (ja) * 2010-09-08 2016-03-02 グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドGlaxosmithkline Intellectual Property Development Limited インフルエンザウィルス感染の治療に使用するためのインダゾール誘導体
AU2011343642A1 (en) * 2010-12-16 2013-05-02 Vertex Pharmaceuticals Incorporated Inhibitors of influenza viruses replication
KR20130128435A (ko) * 2010-12-16 2013-11-26 버텍스 파마슈티칼스 인코포레이티드 인플루엔자 바이러스 복제의 억제제
UA118010C2 (uk) * 2011-08-01 2018-11-12 Вертекс Фармасьютікалз Інкорпорейтед Інгібітори реплікації вірусів грипу
MX359032B (es) 2011-09-01 2018-09-12 Hoffmann La Roche Inhibidores de pirrolopirazina cinasa.
WO2013184985A1 (en) * 2012-06-08 2013-12-12 Vertex Pharmaceuticals Incorporated Inhibitors of influenza viruses replication
LT3068776T (lt) 2013-11-13 2019-08-12 Vertex Pharmaceuticals Incorporated Gripo virusų replikacijos inhibitoriai
SG11201700956VA (en) 2014-08-08 2017-03-30 Janssen Sciences Ireland Uc Indoles for use in influenza virus infection
UY36255A (es) 2014-08-08 2016-01-29 Bayer Cropscience Ag Compuestos sustituidos por halógeno novedosos
UY36249A (es) 2014-08-08 2016-01-29 Bayer Cropscience Ag Compuestos sustituidos con halógeno novedosos
CN104592038A (zh) 2015-01-12 2015-05-06 烟台万润精细化工股份有限公司 一种5,5-二甲基-1,3-环己二胺的制备方法

Similar Documents

Publication Publication Date Title
JP2017523225A5 (cg-RX-API-DMAC7.html)
JP2015024998A5 (cg-RX-API-DMAC7.html)
JP2020507589A5 (cg-RX-API-DMAC7.html)
JP2017531619A5 (cg-RX-API-DMAC7.html)
ZA202006378B (en) N-heterocyclic five-membered ring-containing capsid protein assembly inhibitor, pharmaceutical composition thereof, and use thereof
JP2019501879A5 (cg-RX-API-DMAC7.html)
JP2016518434A5 (cg-RX-API-DMAC7.html)
JP2020531422A5 (cg-RX-API-DMAC7.html)
JP2017531038A5 (cg-RX-API-DMAC7.html)
JP2020532547A5 (cg-RX-API-DMAC7.html)
EA201992082A1 (ru) Ингибитор поверхностного антигена вируса гепатита b
JP2017517565A5 (cg-RX-API-DMAC7.html)
HRP20211278T1 (hr) Supstituirani derivati indolina kao inhibitori replikacije denga virusa
JP2015537020A5 (cg-RX-API-DMAC7.html)
RU2013121788A (ru) Ингибиторы репликации вич
JP2019510034A5 (cg-RX-API-DMAC7.html)
JP2014511891A5 (cg-RX-API-DMAC7.html)
JP2013542247A5 (cg-RX-API-DMAC7.html)
JP2019500387A5 (cg-RX-API-DMAC7.html)
JP2013543896A5 (cg-RX-API-DMAC7.html)
HRP20210038T1 (hr) Pirolopirimidini za uporabu u infekciji virusom gripe
JP2016540742A5 (cg-RX-API-DMAC7.html)
JP2016534063A5 (cg-RX-API-DMAC7.html)
JP2016510326A5 (cg-RX-API-DMAC7.html)
JP2015051983A5 (cg-RX-API-DMAC7.html)